Zimmer Biomet reports increased net sales in third-quarter 2024 financial results
Click Here to Manage Email Alerts
Key takeaways:
- Zimmer Biomet announced its third-quarter 2024 financial results.
- The company reported $1.824 billion in net sales and $249.1 million in net earnings for the quarter.
Zimmer Biomet Holdings Inc. announced its third-quarter 2024 financial results, according to a company press release.
Zimmer Biomet reported $1.824 billion in net sales for the quarter, a 4% increase from the prior year period. The company also reported $249.1 million in net earnings for the quarter and $1.23 in diluted earnings per share.
The report highlighted Zimmer Biomet’s acquisition of OrthoGrid Systems Inc. for AI in total hip arthroplasty.
“We are pleased with the strong performance we delivered in the third quarter, despite our [enterprise resource planning] ERP implementation challenges,” Ivan Tornos, president and CEO of Zimmer Biomet, said in the release. “I am proud of the team and how they came together to manage the ERP issues and mitigate the negative impact on the company’s performance for the year, positioning us to focus on our exciting innovation pipeline and planned new product introductions. We look forward to delivering on our strategic priorities and advancing our mission to help millions of people alleviate pain and improve their quality of life.”
Read more about
Click Here to Manage Email Alerts